About the Company
We do not have any company description for Cocrystal Pharma, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $COCP News
COCP: Topline Data for Influenza A and Dual Coronavirus/Norovirus Programs Expected in 2024; Model Revision Leads to Valuation of $6 Per Share…
COCP READ THE FULL COCP RESEARCH REPORT Business Update Update on Influenza Program Cocrystal Pharma, Inc. (NASDAQ:COCP) is ...
We don't have any news on Cocrystal Pharma, Inc. at the moment.
Loading the latest forecasts...